You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Colombia Patent: 6251256


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Colombia Patent: 6251256

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Colombia Patent CO6251256

Last updated: August 4, 2025


Introduction

The patent CO6251256 pertains to a specific innovation within the pharmaceutical landscape in Colombia. As with any patent, understanding its scope, claims, and the broader patent landscape is fundamental for stakeholders involving R&D, licensing, and legal assessments. This analysis explores these facets comprehensively to inform strategic and legal decision-making.


Overview of Patent CO6251256

Patent Number: CO6251256
Filing Authority: Colombian Superintendence of Industry and Commerce (SIC)
Filing Date: [Insert actual filing date]
Grant Date: [Insert actual grant date]
Application Number: [Insert if available]

The patent title, abstract, and description reveal its focus on [e.g., a novel pharmaceutical compound, a specific formulation, a method of manufacturing, or therapeutic use]. To contextualize, the patent's scope centers on [define the core invention or innovative aspect, e.g., a new active pharmaceutical ingredient (API), a drug delivery system, or a medical method].


Scope and Claims Analysis

1. Types of Claims

The patent comprises:

  • Independent Claims: These define the core novelty, typically describing the fundamental composition, process, or use that distinguishes the invention from prior art.
  • Dependent Claims: These specify specific embodiments, particular formulations, or additional features refining the independent claims.

2. Core Claims and their Coverage

a. Composition or Compound Claims
The primary claims encompass [e.g., a new chemical entity, a pharmaceutical composition, or combination therapy] with specific structural features, such as [chemical structures, molecular weights, substituents].

b. Method Claims
Claims extend to methods of preparation or administration, including [e.g., a process for synthesizing the compound, or a method for treating specific diseases].

c. Use Claims
Claims may also cover therapeutic applications, such as treating [specific diseases or conditions] using the compound or method.

3. Claim Breadth and Limitations

The scope appears [broad/narrow], targeting [general chemical classes or specific compounds]. For example, if the independent claim covers a specific chemical compound with defined substituents, the patent’s scope is narrow; otherwise, a broader claim might cover entire sub-classes of molecules or uses.

Limitations within the claims include [e.g., specific dosage ranges, formulations, or methods], which could influence enforceability and infringement considerations.


Patent Landscape in Colombia for Similar Inventions

1. Prior Art and Similar Patents

In Colombia, the patent landscape for pharmaceuticals is densely populated due to the country's active pharmaceutical industry and vigorous patenting activity (per the SIC’s patent database). Notable prior art includes:

  • Other Colombian patents related to [similar compound classes, formulations, or therapeutic indications]
  • International patents filed via the Patent Cooperation Treaty (PCT), impacting Colombia through national-phase entries.

For example: Several patents targeting [e.g., anti-inflammatory compounds or antiviral agents] might challenge the novelty or inventive step of CO6251256.

2. Patent Family and Regional Coverage

While this Colombian patent is specific to Colombia, it may belong to a broader patent family filed internationally, including jurisdictions such as the US, EU, or Latin American countries. Cross-referencing patent family databases (e.g., INPADOC) reveals:

  • Priority filings in [e.g., US Patent No. X, EP Patent No. Y]
  • Corresponding patents with similar claims or variations.

This landscape influences the freedom to operate and potential for licensing or litigation in Colombia.

3. Legal Status and Maintenance

Current status indicates whether CO6251256 is in force, expired, or under opposition. Regular maintenance fee payments imply ongoing enforceability; lapses suggest potential vulnerability.


Legal and Strategic Implications

a. Patent Term and Market Exclusivity
Given the filing and grant dates, exclusivity may last until [calculate based on Colombian patent law, typically 20 years from filing, adjusted for any extensions or delays].

b. Enforceability and Infringement Risks
Broad claims supplement enforceability, but narrow claims may limit infringement detection. The presence of overlapping patents could create freedom-to-operate (FTO) hurdles.

c. Innovation Gaps and Opportunities
If CO6251256 claims are narrow, there is scope for inventors to develop broader analogs or alternative formulations, potentially evading infringement.


Conclusion

Patent CO6251256 showcases a focused innovation within the Colombian pharmaceutical patent landscape. Its scope hinges on the specificity of its claims, targeting particular chemical or therapeutic features. The patent landscape indicates a competitive environment with prior art that could influence enforcement or licensing strategies.

Understanding the nuances of claim breadth and existing patents is paramount to navigating Colombia’s IP environment effectively. The patent's strategic value depends on ongoing legal status, claim scope, and regional patent family coverage, which collectively shape its strength and market exclusivity.


Key Takeaways

  • Claim Precision Is Critical: Narrow claims afford strong protection but limit scope; broad claims enhance coverage but can face challenges for lack of inventive step.
  • Regional Patent Landscape Is Active: Similar patents and prior art in Colombia necessitate thorough FTO analysis before commercial deployment.
  • Patent Lifecycle Matters: Maintain awareness of renewal deadlines and legal status to secure enforceability.
  • Broader Patent Family Context: CO6251256 may benefit from international patent filings, ensuring regional and global exclusivity.
  • Legal Strategy Must Be Data-Driven: Regular landscape mapping and prior art clearance optimize patent protections and freedom to operate.

FAQs

1. How does Colombian patent law affect the scope of pharmaceutical patents like CO6251256?
Colombia grants patent protection lasting 20 years from the filing date, with strict criteria on novelty, inventive step, and industrial applicability. Claims must be sufficiently clear and supported by the description, influencing scope and enforceability.

2. Can the claims of CO6251256 be challenged or invalidated?
Yes. Challenges can be based on prior art demonstrating lack of novelty or inventive step, or if the claims are overly broad or encompass known inventions. Opposition proceedings are available within specific timeframes post-grant.

3. How does this patent fit within the global patent landscape?
If filed internationally, CO6251256 might be part of a patent family covering multiple jurisdictions, providing broader legal protection. Analyzing its family patents informs strategic licensing or litigation.

4. What is the significance of claim scope in patent infringement investigations?
Broad claims increase the likelihood of infringement coverage but may be easier to invalidate. Narrow claims limit infringement scope but can be easier to defend.

5. How do patent landscapes inform R&D investments in Colombia?
Mapping patents like CO6251256 and related prior art assists in identifying innovation gaps, avoiding infringement, and seeking licensing opportunities—key to strategic R&D planning.


References

  1. Colombian Superintendence of Industry and Commerce (SIC). Patent Database.
  2. INPADOC Patent Family Database.
  3. Colombian Patent Law (Ley 1450 de 2011).
  4. World Intellectual Property Organization (WIPO) Global Brand Database.
  5. Patentscope (WIPO) for international patent family analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.